ArticleJapanese journal of clinical oncology2024

Predictive factors of nivolumab plus ipilimumab treatment efficacy in metastatic renal cell carcinoma patients.

Kojiro Ohba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.